CaMKII and MEK1/2 inhibition time-dependently modify inflammatory signaling in rat cerebral arteries during organ culture

Journal of Neuroinflammation

Lars Edvinsson¹  Leif E Johnson²  Hilda Ahnstedt¹  Sajedeh Eftekhari¹  Roya Waldsee¹ 

[1] Department of Clinical Sciences, Division of Experimental Vascular Research, Lund University, Sölvegatan 17, SE-221 84 Lund, Sweden;Department of Ophthalmology, Division of Clinical Science, Lund University, Klinikgatan 26, SE- 221 85 Lund, Sweden

关键词: p38;    JNK;    Inflammation;    Organ culture;    CaMKII;    ERK1/2;   

Others  :  804168
DOI  :  10.1186/1742-2094-11-90

 received in 2013-10-23, accepted in 2014-05-01,  发布年份 2014

【 摘 要 】

Background

Cerebral ischemia induces transcriptional upregulation of inflammatory genes in the brain parenchyma and in cerebral arteries, thereby contributing to the infarct development. The present study was designed to evaluate the involvement of calcium-calmodulin-dependent protein kinase (CaMKII) II and extracellular signal-regulated kinase1/2 (ERK1/2) on inflammatory mediators in rat cerebral arteries using organ culture as a method for inducing ischemic-like vascular wall changes.

Methods

Rat basilar arteries were cultured in serum-free medium for 0, 3, 6 or 24 hours in the presence or absence of the CaMKII inhibitor KN93 or the MEK1/2 inhibitor U0126. Protein expression of activated CaMKII, ERK1/2, and inflammatory-associated protein kinases and mediators were examined with western blot and immunohistochemistry. Caspase-3 mRNA levels in basilar arteries were studied with real-time PCR.

Results

Western blot evaluation showed that organ culture induced a significant increase in phosphorylated ERK1/2 at 3, 6 and 24 hours, while CaMKII was found to be already activated in fresh non-incubated arteries and to decrease with incubation time. The addition of U0126 or KN93 decreased levels of phosphorylated c-Jun N-terminal kinase and p-p38, as evaluated by immunohistochemistry. KN93 affected the increase in caspase-3 mRNA expression only when given at the start of incubation, while U0126 had an inhibitory effect when given up to six hours later. Tumor necrosis factor receptor 1 was elevated after organ culture. This inflammatory marker was reduced by both of the two different protein kinase inhibitors.

Conclusions

The novel findings of the present study are that the cross-talk between the two protein kinases and the inhibition of CaMKII or MEK1/2 in a time-dependent manner attenuates inflammatory-associated protein kinases and mediators, suggesting that they play a role in cerebrovascular inflammation.

【 授权许可】

   
2014 Waldsee et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

【 参考文献 】

• [1]Lambertsen KL, Biber K, Finsen B: Inflammatory cytokines in experimental and human stroke. J Cereb Blood Flow Metab 2012, 32:1677-1698.
• [2]Etminan N, Vergouwen MD, Ilodigwe D, Macdonald RL: Effect of pharmaceutical treatment on vasospasm, delayed cerebral ischemia, and clinical outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. J Cereb Blood Flow Metab 2011, 31:1443-1451.
• [3]O’Collins VE, Macleod MR, Donnan GA, Horky LL, van der Worp BH, Howells DW: 1,026 experimental treatments in acute stroke. Ann Neurol 2006, 59:467-477.
• [4]Maddahi A, Edvinsson L: Cerebral ischemia induces microvascular pro-inflammatory cytokine expression via the MEK/ERK pathway. J Neuroinflammation 2010, 7:14. BioMed Central Full Text
• [5]Maddahi A, Kruse LS, Chen QW, Edvinsson L: The role of tumor necrosis factor-alpha and TNF-alpha receptors in cerebral arteries following cerebral ischemia in rat. J Neuroinflammation 2011, 8:107. BioMed Central Full Text
• [6]Maddahi A, Povlsen GK, Edvinsson L: Regulation of enhanced cerebrovascular expression of proinflammatory mediators in experimental subarachnoid hemorrhage via the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathway. J Neuroinflammation 2012, 9:274. BioMed Central Full Text
• [7]Vikman P, Ansar S, Henriksson M, Stenman E, Edvinsson L: Cerebral ischemia induces transcription of inflammatory and extracellular-matrix-related genes in rat cerebral arteries. Exp Brain Res 2007, 183:499-510.
• [8]Edvinsson LI, Povlsen GK: Vascular plasticity in cerebrovascular disorders. J Cereb Blood Flow Metab 2011, 31:1554-1571.
• [9]Povlsen GK, Waldsee R, Ahnstedt H, Kristiansen KA, Johansen FF, Edvinsson L: In vivo experimental stroke and in vitro organ culture induce similar changes in vasoconstrictor receptors and intracellular calcium handling in rat cerebral arteries. Exp Brain Res 2012, 219:507-520.
• [10]Shichiri M, Yokokura M, Marumo F, Hirata Y: Endothelin-1 inhibits apoptosis of vascular smooth muscle cells induced by nitric oxide and serum deprivation via MAP kinase pathway. Arterioscler Thromb Vasc Biol 2000, 20:989-997.
• [11]Jamali R, Bao M, Arnqvist HJ: IGF-I but not insulin inhibits apoptosis at a low concentration in vascular smooth muscle cells. J Endocrinol 2003, 179:267-274.
• [12]Bennett MR: Apoptosis in vascular disease. Transpl Immunol 1997, 5:184-188.
• [13]Suhara T, Kim HS, Kirshenbaum LA, Walsh K: Suppression of Akt signaling induces Fas ligand expression: involvement of caspase and Jun kinase activation in Akt-mediated Fas ligand regulation. Mol Cell Biol 2002, 22:680-691.
• [14]Hazzalin CA, Mahadevan LC: MAPK-regulated transcription: a continuously variable gene switch? Nat Rev Mol Cell Biol 2002, 3:30-40.
• [15]Ansar S, Edvinsson L: Subtype activation and interaction of protein kinase C and mitogen-activated protein kinase controlling receptor expression in cerebral arteries and microvessels after subarachnoid hemorrhage. Stroke 2008, 39:185-190.
• [16]Ansar S, Vikman P, Nielsen M, Edvinsson L: Cerebrovascular ETB, 5-HT1B, and AT1 receptor upregulation correlates with reduction in regional CBF after subarachnoid hemorrhage. Am J Physiol Heart Circ Physiol 2007, 293:H3750-H3758.
• [17]Maddahi A, Chen Q, Edvinsson L: Enhanced cerebrovascular expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 via the MEK/ERK pathway during cerebral ischemia in the rat. BMC Neurosci 2009, 10:56. BioMed Central Full Text
• [18]Tombes RM, Grant S, Westin EH, Krystal G: G1 cell cycle arrest and apoptosis are induced in NIH 3 T3 cells by KN-93, an inhibitor of CaMK-II (the multifunctional Ca2+/CaM kinase). Cell Growth Differ 1995, 6:1063-1070.
• [19]Kruidering M, Schouten T, Evan GI, Vreugdenhil E: Caspase-mediated cleavage of the Ca2+/calmodulin-dependent protein kinase-like kinase facilitates neuronal apoptosis. J Biol Chem 2001, 276:38417-38425.
• [20]Henriksson M, Stenman E, Edvinsson L: Intracellular pathways involved in upregulation of vascular endothelin type B receptors in cerebral arteries of the rat. Stroke 2003, 34:1479-1483.
• [21]Henriksson M, Xu CB, Edvinsson L: Importance of ERK1/2 in upregulation of endothelin type B receptors in cerebral arteries. Br J Pharmacol 2004, 142:1155-1161.
• [22]Waldsee R, Ahnstedt H, Eftekhari S, Edvinsson L: Involvement of calcium-calmodulin-dependent protein kinase II in endothelin receptor expression in rat cerebral arteries. Am J Physiol Heart Circ Physiol 2010, 298:H823-H832.
• [23]Smith MR, Kung H, Durum SK, Colburn NH, Sun Y: TIMP-3 induces cell death by stabilizing TNF-alpha receptors on the surface of human colon carcinoma cells. Cytokine 1997, 9:770-780.
• [24]Sprague AH, Khalil RA: Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem Pharmacol 2009, 78:539-552.
• [25]Harrison DC, Medhurst AD, Bond BC, Campbell CA, Davis RP, Philpott KL: The use of quantitative RT-PCR to measure mRNA expression in a rat model of focal ischemia–caspase-3 as a case study. Brain Res Mol Brain Res 2000, 75:143-149.
• [26]Vikman P, Beg S, Khurana TS, Hansen-Schwartz J, Edvinsson L: Gene expression and molecular changes in cerebral arteries following subarachnoid hemorrhage in the rat. J Neurosurg 2006, 105:438-444.
• [27]Beg SA, Hansen-Schwartz JA, Vikman PJ, Xu CB, Edvinsson LI: ERK1/2 inhibition attenuates cerebral blood flow reduction and abolishes ET (B) and 5-HT (1B) receptor upregulation after subarachnoid hemorrhage in rat. J Cereb Blood Flow Metab 2006, 26:846-856.
• [28]Henriksson M, Stenman E, Vikman P, Edvinsson L: MEK1/2 inhibition attenuates vascular ETA and ETB receptor alterations after cerebral ischaemia. Exp Brain Res 2007, 178:470-476.
• [29]Waldsee R: Calcium calmodulin-dependent protein kinase signal transduction in cerebral arteries. Lund University, Faculty of Medicine Doctoral dissertation series; 2011:20.
• [30]Zhang W, Zhang Y, Edvinsson L, Xu CB: Transcriptional down-regulation of thromboxane A (2) receptor expression via activation of MAPK ERK1/2, p38/NF-kappaB pathways. J Vasc Res 2009, 46:162-174.
• [31]Cuschieri J, Bulger E, Garcia I, Jelacic S, Maier RV: Calcium/calmodulin-dependent kinase II is required for platelet-activating factor priming. Shock 2005, 23:99-106.
• [32]Zheng Y, Gardner SE, Clarke MC: Cell death, damage-associated molecular patterns, and sterile inflammation in cardiovascular disease. Arterioscler Thromb Vasc Biol 2011, 31:2781-2786.
• [33]Varfolomeev E, Goncharov T, Maecker H, Zobel K, Komuves LG, Deshayes K, Vucic D: Cellular inhibitors of apoptosis are global regulators of NF-kappaB and MAPK activation by members of the TNF family of receptors. Sci Signal 2012, 5:ra22.
• [34]Oltmanns U, Issa R, Sukkar MB, John M, Chung KF: Role of c-jun N-terminal kinase in the induced release of GM-CSF, RANTES and IL-8 from human airway smooth muscle cells. Br J Pharmacol 2003, 139:1228-1234.
• [35]Park-Min KH, Ji JD, Antoniv T, Reid AC, Silver RB, Humphrey MB, Nakamura M, Ivashkiv LB: IL-10 suppresses calcium-mediated costimulation of receptor activator NF-kappa B signaling during human osteoclast differentiation by inhibiting TREM-2 expression. J Immunol 2009, 183:2444-2455.
• [36]Hughes K, Edin S, Antonsson A, Grundstrom T: Calmodulin-dependent kinase II mediates T cell receptor/CD3- and phorbol ester-induced activation of IkappaB kinase. J Biol Chem 2001, 276:36008-36013.
• [37]Ahnstedt H, Stenman E, Cao L, Henriksson M, Edvinsson L: Cytokines and growth factors modify the upregulation of contractile endothelin ET (A) and ET (B) receptors in rat cerebral arteries after organ culture. Acta Physiol (Oxf) 2012, 205:266-278.